10 additional monthly gift articles to share
在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。，详情可参考heLLoword翻译官方下载
Nominations are now open for this year’s appointments to the F-Droid Board of Directors!，更多细节参见搜狗输入法2026
Marketer Plan: $99/year – that can be used on upto 2 sites。heLLoword翻译官方下载对此有专业解读